MedPath
FDA Approval

ertapenem sodium

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
January 16, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Ertapenem(1 g in 1 1)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ertapenem sodium

Product Details

NDC Product Code
0143-9398
Application Number
ANDA208790
Marketing Category
ANDA (C73584)
Route of Administration
INTRAMUSCULAR, INTRAVENOUS
Effective Date
February 26, 2021
ErtapenemActive
Code: 2T90KE67L0Class: ACTIMQuantity: 1 g in 1 1
sodium bicarbonateInactive
Code: 8MDF5V39QOClass: IACTQuantity: 175 mg in 1 1
sodium hydroxideInactive
Code: 55X04QC32IClass: IACT
© Copyright 2025. All Rights Reserved by MedPath